Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Based on the search results, I'll provide comprehensive information about neomycin sulphate + bacitracin zinc. Neomycin sulphate + bacitracin zinc is a combination antibiotic medication primarily used for topical application. This combination is often formulated with polymyxin B as a triple antibiotic preparation for treating or preventing superficial bacterial infections. ## Composition and Formulation The medication typically contains: - Neomycin sulphate (also spelled sulfate): An aminoglycoside antibiotic - Bacitracin zinc: A polypeptide antibiotic These active ingredients are usually formulated in an ointment base, commonly white petrolatum or mineral oil for topical application[1][2]. ## Mechanism of Action This combination provides a wide spectrum of antibacterial activity through complementary mechanisms: - **Neomycin sulphate**: Bactericidal for many gram-positive and gram-negative organisms. It inhibits protein synthesis by binding with ribosomal RNA and causing misreading of the bacterial genetic code[4]. - **Bacitracin zinc**: Bactericidal for various gram-positive and gram-negative organisms. It interferes with bacterial cell wall synthesis by inhibiting the regeneration of phospholipid receptors involved in peptidoglycan synthesis[4]. ## Clinical Uses The combination is indicated for: 1. Prevention of superficial bacterial skin infections associated with minor cuts, scrapes, or burns[5][9]. 2. Treatment of minor skin infections caused by susceptible bacteria[3][5]. 3. When formulated with polymyxin B, it's used for topical treatment of superficial infections of the external eye and its adnexa[4][8]. ## Microbial Coverage The combination is effective against numerous bacteria including: - Staphylococcus aureus - Streptococci (including Streptococcus pneumoniae) - Escherichia coli - Haemophilus influenzae - Klebsiella-Enterobacter species - Neisseria species - Pseudomonas aeruginosa[4][6] ## Administration The medication is applied topically to the affected area, typically 1-3 times daily or as directed by a healthcare provider[3]. For ophthalmic formulations, specific instructions for eye application must be followed[4][8]. ## Contraindications The medication is contraindicated in: - Individuals with hypersensitivity to any of the components - For ophthalmic formulations: viral diseases of the cornea and conjunctiva, mycobacterial infections, and fungal diseases of ocular structures[6] - Not for injection into the eye or for use in the external ear canal if the eardrum is perforated[5][6] ## Precautions - For external use only - Avoid contact with eyes (for skin formulations) - Prolonged use may lead to overgrowth of non-susceptible organisms - Discontinue use if irritation or hypersensitivity reactions occur[2][5] This combination antibiotic provides effective broad-spectrum coverage for superficial bacterial infections and is available in various formulations for different clinical applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neomycin sulphate + Bacitracin zinc.